Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2026-06-14 @ 5:06 PM
Study NCT ID:
NCT01048034
Status:
COMPLETED
Last Update Posted:
2013-10-29
First Post:
2010-01-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Sponsor:
Nordic MDS Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
NMDSG08A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None